HOME     |     LANGUAGE/COUNTRY     |     SHOP


Search  

Semex News

SEMEX ANNOUNCES NEW LEADERSHIP AT SEMEX FRANCE
Semex is pleased to announce new leadership at Semex France, with Arnaud Botrel as its new Owner-Di...
BOVITEQ ANNOUNCES NEW LICENSEE SERVING SPAIN & PORTUGAL
Boviteq is thrilled to announce the strategic selection of a new licensee location in Spain. This n...
SEMEX SEMI-FINALIST IN CANADIAN AG METHANE REDUCTION CHALLENGE
Semex is excited to announce that it is one of 13 semi-finalists from 86 applications in Agricult...
SEMEX ANNOUNCES NEW LEADERSHIP TEAM AT SEMEX ARGENTINA
Semex is pleased to announce a new leadership team at Semex Argentina, with the retirement of Gen...
LARMER INDUCTED INTO THE CANADIAN AGRICULTURAL HALL OF FAME
Semex proudly announces that former CEO Paul Larmer will be inducted into the Canadian Agricultural...
SEMEX ADDS TROPICAL BREEDS TO THE PROGENESIS PROGRAM
At Semex we know Beef production must increase from 60 million to 130 million tons by 2050 to fee...

View All Articles
BOVITEQ ANNOUNCES NEW LICENSEE SERVING SPAIN & PORTUGAL
Article posted on August 22, 2024, 16:55:33

Boviteq is thrilled to announce the strategic selection of a new licensee location in Spain. This new IVF partner will combine its local intelligence with Boviteq knowledge to deliver the industry’s leading IVF services to clients.



Now, clients in Spain and Portugal through Embriovet have access to Boviteq’s excellent products and services, promising a brighter future for the industry.



“With the growth in IVF services and the extreme demand for our product worldwide, we seek partners to work shoulder-to-shoulder with bovine producers.  Embriovet is a logical choice,” says Melissa Bowers, Semex Vice President, Embryo Division. “Embriovet and Dr. Daniel Bello share our values of excellent service and client relationships along with an embryo philosophy that meshes with our own, making them ideal partners.”



"We are very excited to be partners with Boviteq,” says Dr. Bello. “We have worked in the embryo world for 30 years and always seek excellence. With Boviteq, we take a qualitative leap by incorporating the most advanced technology and accessing the knowledge and experience accumulated by one of the most prestigious groups recognized worldwide. Our clients make significant efforts and investments in genetic improvement and deserve that we support them with the best tools at our disposal. Improving the production of high-quality in vitro embryos with proven freezing technology that facilitates direct transfer will rejuvenate the domestic and export markets, giving us a solid base from which to grow.”




Print this Article | Email this Article